Chargement en cours...
Advanced Pancreatic Ductal Adenocarcinoma: Moving Forward
Globally, the death rate of pancreatic ductal adenocarcinoma (PDAC) has doubled over 30 years and is likely to further increase, making PDAC a leading cause of cancer-related death in the coming years. PDAC is typically diagnosed at an advanced stage, and modified FOLFIRINOX or nab-paclitaxel and ge...
Enregistré dans:
| Publié dans: | Cancers (Basel) |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7409054/ https://ncbi.nlm.nih.gov/pubmed/32708493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12071955 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|